B. Metzler seel. Sohn & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28M | Hold |
76,244
| – | – | 0.01% | 481 |
|
|
2025
Q1 | $1.17M | Hold |
76,244
| – | – | 0.01% | 483 |
|
|
2024
Q4 | $1.68M | Buy |
76,244
+50,995
| +202% | +$1.12M | 0.02% | 412 |
|
|
2024
Q3 | $455K | Hold |
25,249
| – | – | ﹤0.01% | 656 |
|
|
2024
Q2 | $410K | Buy |
25,249
+1,087
| +4% | +$17.7K | ﹤0.01% | 655 |
|
|
2024
Q1 | $341K | Hold |
24,162
| – | – | ﹤0.01% | 667 |
|
|
2023
Q4 | $252K | Sell |
24,162
-50,237
| -68% | -$524K | ﹤0.01% | 710 |
|
|
2023
Q3 | $759K | Buy |
74,399
+50,237
| +208% | +$512K | 0.01% | 519 |
|
|
2023
Q2 | $182K | Hold |
24,162
| – | – | ﹤0.01% | 726 |
|
|
2023
Q1 | $214K | Hold |
24,162
| – | – | ﹤0.01% | 698 |
|
|
2022
Q4 | $220K | Hold |
24,162
| – | – | ﹤0.01% | 686 |
|
|
2022
Q3 | $195K | Hold |
24,162
| – | – | ﹤0.01% | 712 |
|
|
2022
Q2 | $182K | Hold |
24,162
| – | – | ﹤0.01% | 708 |
|
|
2022
Q1 | $227K | Hold |
24,162
| – | – | ﹤0.01% | 740 |
|
|
2021
Q4 | $191K | Buy |
24,162
+9,246
| +62% | +$73.1K | ﹤0.01% | 705 |
|
|
2021
Q3 | $145K | Hold |
14,916
| – | – | ﹤0.01% | 695 |
|
|
2021
Q2 | $148K | Buy |
+14,916
| New | +$148K | ﹤0.01% | 678 |
|